LLY

1,086.02

+0.46%↑

JNJ

232.42

+0.61%↑

ABBV

215.42

+0.48%↑

UNH

383.37

+1.29%↑

AZN

187.41

-0.42%↓

LLY

1,086.02

+0.46%↑

JNJ

232.42

+0.61%↑

ABBV

215.42

+0.48%↑

UNH

383.37

+1.29%↑

AZN

187.41

-0.42%↓

LLY

1,086.02

+0.46%↑

JNJ

232.42

+0.61%↑

ABBV

215.42

+0.48%↑

UNH

383.37

+1.29%↑

AZN

187.41

-0.42%↓

LLY

1,086.02

+0.46%↑

JNJ

232.42

+0.61%↑

ABBV

215.42

+0.48%↑

UNH

383.37

+1.29%↑

AZN

187.41

-0.42%↓

LLY

1,086.02

+0.46%↑

JNJ

232.42

+0.61%↑

ABBV

215.42

+0.48%↑

UNH

383.37

+1.29%↑

AZN

187.41

-0.42%↓

Начало・Списък с акции・Hutchison China MediTech Ltd ADR
Search

Hutchison China MediTech Ltd ADR

Отворен

СекторЗдравеопазване

11.16 -5.18

Купи

Обновена цена 27.05.2026 г., 15:32 ч. UTC

КупиПродай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

11.16

Максимум

11.75

Ключови измерители

By Trading Economics

Приходи

227M

Продажби

139M

P/E

Средно за сектора

4.522

50.102

Марж на печалбата

163.843

Служители

1,796

EBITDA

1.3M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+66.81% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

2.1B

Предишно отваряне

16.34

Предишно затваряне

11.16

Настроения в новините

By Acuity

10%

90%

7 / 344 Класиране в Healthcare

Hutchison China MediTech Ltd ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.05.2026 г., 16:52 ч. UTC

Значими събития в новините

NYMEX Overview: Brent Crude Futures Up; Iran Warns of Retaliation After US Strike -- OPIS

DJ

Прочетени

26.05.2026 г., 23:57 ч. UTC

Печалби

Sociedad Quimica 1Q Rev $1.76B >SQM

DJ

Прочетени

26.05.2026 г., 23:57 ч. UTC

Печалби

Sociedad Quimica 1Q EPS $1.28 >SQM

DJ

Прочетени

26.05.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise on Continued AI Enthusiasm -- Market Talk

DJ

Прочетени

26.05.2026 г., 21:54 ч. UTC

Печалби

Webco Industries 3Q EPS $11.61 >WEBC

DJ

Прочетени

26.05.2026 г., 21:54 ч. UTC

Печалби

Webco Industries 3Q Sales $179.6M >WEBC

DJ

Прочетени

26.05.2026 г., 21:48 ч. UTC

Пазарно говорене

GE Aerospace's Repair Boom Should Last for Years -- Market Talk

DJ

Прочетени

26.05.2026 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 20:58 ч. UTC

Придобивния, сливания и поглъщания

Uber's $11.6 Billion Bid for DoorDash Rival Is About Future Proofing It From Robots -- Barrons.com

DJ

Прочетени

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 19:22 ч. UTC

Пазарно говорене

Cryptocurrencies Add to Losses in Afternoon Trading -- Market Talk

DJ

Прочетени

26.05.2026 г., 19:17 ч. UTC

Пазарно говорене

Oil Recovers Some Losses on U.S.-Iran Skirmishes -- Market Talk

DJ

Прочетени

26.05.2026 г., 18:56 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Slip in Rangebound Trading -- Market Talk

DJ

Прочетени

26.05.2026 г., 18:03 ч. UTC

Пазарно говорене

AutoCanada Faces Soft Demand, Slow Normalization -- Market Talk

DJ

Прочетени

26.05.2026 г., 17:42 ч. UTC

Пазарно говорене

Grains Await Fresh Trading Catalyst -- Market Talk

DJ

Прочетени

26.05.2026 г., 17:33 ч. UTC

Пазарно говорене

Salesforce, Snowflake Could Dispel Software Bear Thesis -- Market Talk

DJ

Прочетени

26.05.2026 г., 17:21 ч. UTC

Пазарно говорене

Canada Faces a Labor Market Squeeze -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:52 ч. UTC

Пазарно говорене

Bonds to Fund Infrastructure for Data Centers Could Be Risky -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:43 ч. UTC

Пазарно говорене

Spotify's Latest Audio Play: Magazine Articles -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:24 ч. UTC

Пазарно говорене

Dollarama's LATAM Slowdown, Australia Costs Seen as Transient -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:21 ч. UTC

Пазарно говорене

Oil Extends Gains As Strikes Add Tension to U.S.-Iran Talks -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 16:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Auto & Transport Roundup: Market Talk

DJ

Прочетени

26.05.2026 г., 16:16 ч. UTC

Пазарно говорене

Alberta Separation Threat Poses Headwind for Canada Dollar -- Market Talk

DJ

Прочетени

26.05.2026 г., 16:01 ч. UTC

Пазарно говорене

Bitcoin Lower as Stress Builds for Holders -- Market Talk

DJ

Прочетени

26.05.2026 г., 15:21 ч. UTC

Пазарно говорене

Hyperliquid Pushes Up to New All-Time High -- Market Talk

DJ

Прочетени

Сравнение с други в отрасъла

Ценова промяна

Hutchison China MediTech Ltd ADR Прогноза

Ценова цел

By TipRanks

66.81% нагоре

12-месечна прогноза

Среден 20 USD  66.81%

Висок 20 USD

Нисък 20 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Hutchison China MediTech Ltd ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Според 1 анализатори, дали борсови рейтинги на Hutchison China MediTech Ltd ADR през последните 3 месеца.

Настроение

By Acuity

7 / 344 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

Други акции от сектора

LLY

Eli Lilly and Co.

1,086.02

↑ +0.46%

JNJ

Johnson and Johnson

232.42

↑ +0.61%

ABBV

AbbVie Inc

215.42

↑ +0.48%

UNH

UnitedHealth Group Inc

383.37

↑ +1.29%

AZN

AstraZeneca PLC

187.41

↓-0.42%
help-icon Live chat